Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Children's cancers, Leukaemia
Closed
Phase 1
This trial is looking at clofarabine and liposomal daunorubicin for children and young people who have acute myeloid leukaemia (AML).
This trial is for children and teenagers up to the age of 18. We use the term ‘you’ in this summary, but if you are a parent, we are referring to your child.
Recruitment start: 1 June 2009
Recruitment end: 1 June 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Pamela Kearns
Bloodwise
Cancer Research UK Clinical Trials Unit University of Birmingham
Children's Cancer and Leukaemia Group (CCLG)
Experimental Cancer Medicine Centre (ECMC)
Genzyme Co
NIHR Clinical Research Network: Cancer
Last reviewed: 18 Dec 2023
CRUK internal database number: 4631